Press Release

View all news

Incyte to Present at Upcoming Investor Conferences

October 18, 2023 at 8:00 AM EDT

WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 18, 2023-- Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:

  • Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology (INI) Conference on Tuesday, November 7, 2023 at 1:10 pm (EST)
  • Evercore ISI 6th Annual HealthCONx Conference on Thursday, November 30, 2023 at 12:30 pm (EST)

The presentations will be webcast live and can be accessed at and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.



Source: Incyte